Gumalad, Gabriel .

HRN: 22-34-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2022
CEFTRIAXONE 1G (VIAL)
12/21/2022
12/27/2022
IVT
900mg
Q12
T/C Bacterial Meningitis
Waiting Final Action 
12/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/25/2022
01/01/2023
IVT
1.8 G
8 Hrs
Autoimmune Encephalitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: